Dr. Reddy's Laboratories Reports Mixed Financial Results with Record Sales and Profitability in March 2025

May 09 2025 06:03 PM IST
share
Share Via
Dr. Reddy's Laboratories announced its financial results for the quarter ending March 2025, showcasing record net sales and profit after tax. While earnings per share increased, profit before tax showed a decline compared to previous quarters, highlighting mixed performance trends in the company's financial health.
Dr. Reddy's Laboratories has reported its financial results for the quarter ending March 2025, revealing a mix of positive and challenging trends. The company achieved net sales of Rs 8,528.40 crore, marking the highest quarterly sales in the last five quarters, with a favorable near-term sales trajectory. Additionally, the profit after tax (PAT) reached Rs 1,593.30 crore, also the highest in the same period, indicating a positive trend in profitability. Earnings per share (EPS) stood at Rs 19.10, reflecting an increase in earnings for shareholders.

However, not all aspects of the financial results were favorable. The profit before tax, excluding other income, was reported at Rs 1,483.10 crore, which represents a decline compared to the average of the previous four quarters. This suggests a negative trend in this area. Furthermore, while non-operating income reached Rs 522.10 crore, its sustainability may be in question, as it stems from activities outside the core business.

Overall, Dr. Reddy's Laboratories has experienced evaluation changes in its financial performance, with adjustments reflecting the mixed results of the quarter.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News